-
EP0967979
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0967979
| EP0967979 - THE USE OF LEVOBUPIVACAINE OR ROPIVACAINE IN TREATING MIGRAINE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 05.03.2004 Database last updated on 10.05.2025 | Most recent event Tooltip | 05.03.2004 | Application deemed to be withdrawn | published on 21.04.2004 [2004/17] | Applicant(s) | For all designated states Darwin Discovery Limited 208 Bath Road Slough Berks SL1 3WE / GB | [N/P] |
| Former [2003/05] | For all designated states Darwin Discovery Limited 208 Bath Road Slough Berks SL1 3WE / GB | ||
| Former [2000/01] | For all designated states Darwin Discovery Limited Cambridge Science Park, Milton Road Cambridge CB4 4WE / GB | Inventor(s) | 01 /
EVETTS, Ian Ashley, Darwin Discovery Limited Cambridge Science Park, Milton Road Cambridge CB4 4WE / GB | 02 /
GUNNING, Simon John, Darwin Discovery Limited Cambridge Science Park, Milton Road Cambridge CB4 4WE / GB | [2000/01] | Representative(s) | Perry, Robert Edward Gill Jennings & Every LLP The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB | [N/P] |
| Former [2000/01] | Perry, Robert Edward GILL JENNINGS & EVERY Broadgate House 7 Eldon Street London EC2M 7LH / GB | Application number, filing date | 98908228.4 | 03.03.1998 | [2000/01] | WO1998GB00662 | Priority number, date | GB19970004349 | 03.03.1997 Original published format: GB 9704349 | [2000/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9838998 | Date: | 11.09.1998 | Language: | EN | [1998/36] | Type: | A1 Application with search report | No.: | EP0967979 | Date: | 05.01.2000 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.09.1998 takes the place of the publication of the European patent application. | [2000/01] | Search report(s) | International search report - published on: | EP | 11.09.1998 | Classification | IPC: | A61K31/445 | [2000/01] | CPC: |
A61K31/445 (EP,KR,US);
A61P25/06 (EP)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [2000/01] | Title | German: | VERWENDUNG VON LEVOBUPIVACAINE ODER ROPIVACAINE IN DER BEHANDLUNG VON MIGRÄNE | [2000/01] | English: | THE USE OF LEVOBUPIVACAINE OR ROPIVACAINE IN TREATING MIGRAINE | [2000/01] | French: | UTILISATION DE LA LEVOBUPIVACAINE OU DE LA ROPIVACAINE DANS LE TRAITEMENT DE LA MIGRAINE | [2000/01] | Entry into regional phase | 13.09.1999 | National basic fee paid | 13.09.1999 | Designation fee(s) paid | 13.09.1999 | Examination fee paid | Examination procedure | 24.08.1998 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 13.09.1999 | Examination requested [2000/01] | 07.05.2001 | Despatch of a communication from the examining division (Time limit: M06) | 07.11.2001 | Reply to a communication from the examining division | 21.03.2002 | Despatch of a communication from the examining division (Time limit: M06) | 13.01.2003 | Reply to a communication from the examining division | 31.03.2003 | Despatch of a communication from the examining division (Time limit: M06) | 11.10.2003 | Application deemed to be withdrawn, date of legal effect [2004/17] | 18.11.2003 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2004/17] | Request for further processing for: | 13.01.2003 | Request for further processing filed | 10.01.2003 | Full payment received (date of receipt of payment) Request granted | 06.02.2003 | Decision despatched | Fees paid | Renewal fee | 13.03.2000 | Renewal fee patent year 03 | 16.03.2001 | Renewal fee patent year 04 | 13.03.2002 | Renewal fee patent year 05 | 11.03.2003 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO9510276 (CHIROSCIENCE LTD [GB], et al) [Y] 1 * page 3, lines 21-23; claims 1,4 *; | [PX]GB2315673 (MERCK & CO INC [US]) [PX] 1* abstract *; | [Y] - GRISTWOOD R ET AL, "REDUCED CARDIOTOXICITY OF LEVOBUPIVACAINE COMPARED WITH RACEMIC BUPIVACAINE (MARCAINE): NEW CLINICAL EVIDENCE", EXPERT OPINION ON INVESTIGATIONAL DRUGS, (199411), vol. 3, no. 11, pages 1209 - 1212, XP000610836 [Y] 1 * page 1211, column R, paragraph L * | [DY] - M.BARTH ET AL, "EFFECTS OF APPLICATION OF I.V. WITH LOAL ANAESTHESIA ON CHRONIC PAIN SYNDROMES, ESPECIALLY HEADACHE AND MIGRAINE", PAIN, AMSTERDAM, THE NETHERLANDS, (1984), page S269, XP002068058 [DY] 1 * abstract * DOI: http://dx.doi.org/10.1016/0304-3959(84)90536-0 |